Inspire Medical Systems (INSP) Stock: Buy, Sell, or Hold?
INSP - Inspire Medical Systems, Inc.
$73.00
4.88 (7.16%)
▲
5d:
+17.48%
30d:
+25.26%
90d:
+72.01%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Nov 02, 2026
Get Alerted When INSP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: INSP is 12.3% above its trading range ($64.98). Market expects 8.5% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: INSP is 12.3% above its trading range ($64.98). Market expects 8.5% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$72.20
Based on 13.7% avg growth
INTRINSIC VALUE TODAY
$44.83
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: INSP is currently trading at $73.00, which is considered extended relative to its 30-day fair value range of $57.57 to $64.98. From a valuation perspective, the stock is trading at a premium (Forward PE: 47.5) compared to its historical average (37.2). At these levels, the market is pricing in 8.5% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, INSP is in a uptrend. The price is approaching resistance at $74.95. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 7.2% recently.
Market Sentiment: INSP scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $60.40. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, INSP is in a uptrend. The price is approaching resistance at $74.95. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 7.2% recently.
Market Sentiment: INSP scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $60.40. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$57.57 -
$64.98
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
14.3%
Protect Your Profits
INSP is technically overbought (RSI 76). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+12.3% above its trading range)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+7.2%)
- BEARISH: Trading 17.3% above Wall St target ($60.40)
- NEUTRAL: PE elevated vs history but 8.5% growth expectation is conservative given 308% recent growth
- WARNING: Composite score 43/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$57.57 -
$64.98
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$60.00
Resistance Level
$74.95
Current Trend
Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
47.50
Wall Street Target
$60.40
(-17.3%)
Revenue Growth (YoY)
-7.6%
Earnings Growth (YoY)
308.4%
Profit Margin
15.0%
Valuation Premium vs History
+8.5% premium
PE vs Historical
47.5 vs 37.2
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+8.5%
(market-implied from PE analysis)
1-Year Target
$79.20
(+9%)
2-Year Target
$85.94
(+18%)
3-Year Target
$93.24
(+28%)
3-Yr Target (if PE normalizes)
(PE: 48→37)
PE COMPRESSION
$73.03
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 47.5, Growth: 23.3%)
$136.76
(+87%)
Base:
(SPY PE: 20.2, Growth: 23.3%)
$58.08
(-20%)
Bear:
(PE: 17.1, Growth: 23.3%)
$49.37
(-32%)
📈
Valuation based on Current Earnings
Trailing PE: 14.68 | Current EPS (TTM): $4.64
Bull Case
$37.47
(-49%)
Analyst growth -50.0%, PE expands to 16.2
Base Case
$34.06
(-53%)
Market implied -50.0%, PE stable at 14.7
Bear Case
$46.32
(-37%)
Severe decline -20.0%, PE contracts to 12.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: September 11, 2026 9:04 PM ET
Data refreshes hourly during market hours. Next update: 10:04 PM
Data refreshes hourly during market hours. Next update: 10:04 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INSP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$63 | 49 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$383 | 44 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$105 | 52 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 56 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 41 HOLD |
Advanced INSP Option Strategies
Professional options setups generated by AI based on today's INSP price and gamma walls.
